Parallax Volatility Advisers’s Novartis NVS Stock Holding History

Parallax Volatility Advisers’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,700	Closed	-$944K	–	1972
2024 Q4	$944K	Hold	9,700	–	–	﹤0.01%	1349
2024 Q3	$1.12M	Sell	9,700 -20,200	-68%	-$2.29M	﹤0.01%	1330
2024 Q2	$3.18M	Buy	+29,900	New	+$3M	0.01%	871
2024 Q1	–	Sell	-15,600	Closed	-$1.58M	–	2197
2023 Q4	$1.58M	Sell	15,600 -9,400	-38%	-$907K	﹤0.01%	1247
2023 Q3	$2.55M	Sell	25,000 -4,400	-15%	-$447K	0.01%	1007
2023 Q2	$2.97M	Sell	29,400 -102,700	-78%	-$10.3M	0.01%	980
2023 Q1	$12.2M	Buy	132,100 +2,600	+2%	+$227K	0.02%	520
2022 Q4	$11.7M	Sell	129,500 -113,900	-47%	-$9.59M	0.02%	720
2022 Q3	$18.5M	Buy	+243,400	New	+$20.2M	0.03%	535
2022 Q1	–	Sell	-34,700	Closed	-$3.04M	–	3229
2021 Q4	$3.04M	Buy	34,700 +100	+0.3%	+$8.3K	﹤0.01%	1429
2021 Q3	$2.83M	Buy	+34,600	New	+$3.11M	﹤0.01%	1501
2021 Q1	–	Sell	-2,700	Closed	-$255K	–	3529
2020 Q4	$255K	Hold	2,700	–	–	﹤0.01%	2711
2020 Q3	$235K	Sell	2,700 -400	-13%	-$34.7K	﹤0.01%	2487
2020 Q2	$270K	Sell	3,100 -12,500	-80%	-$1.08M	﹤0.01%	2164
2020 Q1	$1.29M	Sell	15,600 -10,700	-41%	-$955K	﹤0.01%	1397
2019 Q4	$2.49M	Sell	26,300 -14,900	-36%	-$1.34M	﹤0.01%	1174
2019 Q3	$3.58M	Buy	41,200 +3,400	+9%	+$305K	﹤0.01%	924
2019 Q2	$3.45M	Buy	37,800 +12,244	+48%	+$1.04M	﹤0.01%	856
2019 Q1	$2.2M	Buy	+25,556	New	+$2.05M	﹤0.01%	966
2018 Q1	–	Sell	-29,909	Closed	-$2.25M	–	3602
2017 Q4	$2.25M	Buy	+29,909	New	+$2.26M	﹤0.01%	883
2017 Q3	–	Sell	-5,022	Closed	-$376K	–	2866
2017 Q2	$376K	Buy	+5,022	New	+$356K	﹤0.01%	1300
2016 Q3	–	Sell	-6,808	Closed	-$503K	–	3580
2016 Q2	$503K	Buy	+6,808	New	+$470K	﹤0.01%	1460
2013 Q4	–	Sell	-145,638	Closed	-$10M	–	3507
2013 Q3	$10M	Sell	145,638 -85,151	-37%	-$5.63M	0.05%	261
2013 Q2	$14.6M	Buy	+230,789	New	+$15M	0.07%	216

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parallax Volatility Advisers's NVS Position: Q2 2026 in Review

Parallax Volatility Advisers opened a new position in Novartis (NVS) in Q2 2026: 1,602 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1210 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in NVS as recently as Q4 2024.

Parallax Volatility Advisers first reported a position in NVS in Q3 2018 and has held it in 13 quarters since. The position peaked at $18M in Q1 2019. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Parallax Volatility Advisers held 1,602 shares of Novartis worth $251K as of Q2 2026.
Novartis was a new Parallax Volatility Advisers position in Q2 2026.
Novartis made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #1210 holding.
Parallax Volatility Advisers first reported a position in Novartis in Q3 2018 and has held it in 13 quarters since.
Parallax Volatility Advisers's Novartis position peaked at $18M in Q1 2019.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.